National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Rhabdomyosarcoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 11/06/2009
Table 1. Definition of Terms

Term  Definition 
Favorable site Orbit; nonparameningeal head and neck; genitourinary tract excluding kidney, bladder, and prostate; biliary tract.
Unfavorable site Any site other than favorable.
T1 Tumor confined to anatomic site of origin.
T2 Tumor extension and/or fixation to surrounding tissue.
a Tumor ≤5 cm in maximum diameter.
b Tumor >5 cm in maximum diameter.
N0 No clinical regional lymph node involvement.
N1 Clinical regional lymph node involvement.
NX Regional lymph nodes not examined; no information.
M0 No metastatic disease.
M1 Metastatic disease.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov